Metabolism - Clinical and Experimental
Volume 56, Issue 8 , Pages 1099-1103 , August 2007

Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients

  • Ataru Taniguchi

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • Isogai Medical Clinic, Osaka 532-0003, Japan
    • Corresponding Author InformationCorresponding author. Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka-city, Osaka 553-0003, Japan. Fax: +81 6 6458 6994.
    • ,
  • Mitsuo Fukushima

      Affiliations

    • Department of Health Informatics Research, Translational Research Informatics Center, Foundation for Biochemical Research and Innovation, Kobe 650-0047, Japan
    • ,
  • Akira Kuroe

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Kenji Sakaguchi

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Hiroko Hashimoto

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Ikuko Yoshioka

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Naomi Kitatani

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Tomoko Tsuji

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Michihiro Ohya

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Minako Ohgushi

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan
    • ,
  • Shoichiro Nagasaka

      Affiliations

    • Department of Endocrinology and Metabolism, Jichi Medical School of College, Tochigi 700-0045, Japan
    • ,
  • Okihisa Isogai

      Affiliations

    • Isogai Medical Clinic, Osaka 532-0003, Japan
    • ,
  • Yoshikatsu Nakai

      Affiliations

    • Karasuma-Oike Nakai Clinic, Kyoto 604-0845, Japan
    • ,
  • Nobuya Inagaki

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
    • ,
  • Yutaka Seino

      Affiliations

    • Division of Diabetes and Clinical Nutrition, Kansai-Denryoku Hospital, Osaka 553-0003, Japan

Received 28 January 2006 ,Accepted 28 July 2006.

References 

  1. Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity (review). Endocr Rev. 1998;19:491–503
  2. Bergman RN. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes. 1989;38:1512–1527
  3. Welch S, Gebhart SSP, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test–derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab. 1990;71:1508–1518
  4. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, et al. Pathogenic factors responsible for glucose tolerance in patients with NIDDM. Diabetes. 1992;41:1540–1546
  5. Nagasaka S, Tokuyama K, Kusaka I, Hayashi H, Rokkaku K, Nakamura T, et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes. 1999;48:1054–1060
  6. Taniguchi A, Nakai Y, Tokuyama K, Sakai M, Doi K, Fukushima M, et al. Role of glucose effectiveness in the evolution of NIDDM. In:  Berman RN,  Lovejoy JC editor. The minimal model approach and determinants of glucose tolerance. vol. 7:Louisiana State University Press; 1997;p. 357–367
  7. Haffner SM, D'Agostino R, Mykkanen L, Tracy R, Howard B, Rewers M, et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999;22:562–568
  8. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Suzuki H, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53:831–835
  9. Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non–insulin-dependent diabetic patients. Metabolism. 2000;49:1001–1005
  10. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care. 2000;23:1766–1769
  11. Yatagai T, Nagasaka S, Fukushima M, Taniguchi A, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in subjects with type 2 diabetes mellitus. Metabolism. 2003;52:1274–1278
  12. Okumura T, Taniguchi A, Nagasaka S, Sakai M, Fukushima M, Kuroe A, et al. Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients. Diabetes Metab. 2003;29:15–18
  13. Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism. 2002;51:544–548
  14. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducinetiere P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 1989;32:300–304
  15. Shinada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta. 2004;344:1–12
  16. Wallace AM, McMahon AD, Packard CJ, MIBiol AK, Shepherd J, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 2001;104:3052–3056
  17. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2002;24:683–689
  18. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–468
  19. World Health Organization . Diabetes mellitus: report of a WHO study group. Geneva: World Health Org; 1985;[Tech. Rep. Ser., no. 727]
  20. Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, et al. Three measures of tumor necrosis factor-alpha activity and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism. 2005;54:1297–1301
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  22. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care. 2000;23:57–63
  23. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagichi T, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22:818–822
  24. Taniguchi A, Nishimura F, Murayama Y, Nagasaka S, Fukushima M, Sakai M, et al. Porphyromonas gingivalis infection is associated with carotid atherosclerosis in non-obese Japanese type 2 diabetic patients. Metabolism. 2003;52:142–145
  25. Chaiken RL, Banerji MA, Pasmantier RM, Huey H, Hirsch S, Lebovitz HE. Patterns of glucose and lipid abnormalities in black NIDDM subject. Diabetes Care. 1991;14:1036–1042
  26. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen K-W, Leonetti DL, Newell-Morris L, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care. 1999;22:1808–1812
  27. Guha M, Bai W, Nadler J, Natarajan BR. Molecular mechanisms of alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress dependent and independent pathways. J Biol Chem. 2000;275:17728–17735
  28. Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, et al. A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care. 2005;28:1376–1382
  29. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060–3067
  30. Kawasaki Y, Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Ohya M, et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res. 2005;37:617–621
  31. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes. The Casale Monferrato Study. Diabetes Care. 2004;27:2689–2694
  32. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2005;28:2289–2304

PII: S0026-0495(07)00129-1

doi: 10.1016/j.metabol.2006.07.027

Metabolism - Clinical and Experimental
Volume 56, Issue 8 , Pages 1099-1103 , August 2007

Article Tools